Similarly, in prostate cancer, the widespread use of prostate-specific antigen (PSA) testing has led to a marked increase in the detection of prostate cancers, including many low-grade tumours that may never become life-threatening [15]. This evidence concerns the gene KLK3 and prostate cancer.